The acquisition will support Konovo’s work on patient-centric insights across therapeutic areas, in particular for rare and complex medical conditions.

Rare Patient Voice was launched in 2013 and works across nine countries. Konovo will preserve Rare Patient Voice’s approach while supporting it with platform infrastructure.

Tal Rosenberg, chief executive officer at Konovo, said acquiring Rare Patient Voice would help to bring together “authentic patient perspectives with physician insights” to support researchers. 

Wes Michael, founder and president of Rare Patient Voice, said: “The combination of RPV’s community-centric approach and Konovo’s platform scale creates new opportunities for researchers to engage patient and caregiver audiences more effectively.”